2023-02-02 05:19:36 SHEL Shell
02/02/23 02/0205:19 02/02/2305:19 | Shell announces $4B share buyback programShell announced the commencement of a $4B share buyback program covering an aggregate contract term of approximately three months. The purpose of the program is to reduce the issued share capital of the company. All shares repurchased as part of the program will be cancelled. It is intended that, subject to market conditions, the program will be completed prior to the company's Q1 results announcement, scheduled for May 4. The company has entered into an arrangement with a single broker consisting of three irrevocable, non-discretionary contracts, to enable the purchase of ordinary shares on both London market exchanges and Netherlands exchanges for a period up to and including April 28. The aggregate maximum consideration for the purchase of ordinary shares under the London contracts is $2.25B and the maximum consideration for the purchase of ordinary shares under the Netherlands contract is $1.75B. Purchases under the London contracts will be carried out in accordance with the company's authority to repurchase shares on-market and will be effected within certain contractually agreed parameters. Purchases under the Netherlands contract will be carried out in accordance with the company's authority to repurchase shares off-market pursuant to the off-market share buyback contract approved by its shareholders and the parameters set out therein. The maximum number of ordinary shares which may be purchased or committed to be purchased by the company under the program is 387,374,130, which is the maximum number remaining as of the date of this announcement pursuant to the relevant authorities granted by shareholders at the company's 2022 Annual General Meeting. |
|
---|
Periodicals
|
Twitter loses another senior executive in charge of content, safety, WSJ says »
17:46 06/03/23 06/0317:46 06/03/2317:46
TWTR
A second senior executive… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Janssen Pharmaceuticals announces updated data from Phase 2 TRiMM-2 study »
17:39 06/03/23 06/0317:39 06/03/2317:39
JNJ
Johnson & Johnson
The Janssen… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Janssen presents analysis of infections, parameters in Monumen-TAL1 study »
17:39 06/03/23 06/0317:39 06/03/2317:39
JNJ
Johnson & Johnson
The Janssen… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Janssen Pharmaceuticals announced results from Phase 1/2 MonumenTAL-1 study »
17:39 06/03/23 06/0317:39 06/03/2317:39
JNJ
Johnson & Johnson
The Janssen… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Replimune Group announces 3 trial-in-progress abstracts at ASCO »
17:26 06/03/23 06/0317:26 06/03/2317:26
REPL
Replimune Group
Additional Abstracts… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Replimune presents data from Phase 1 trial of RP2 with nivolumab at ASCO »
17:26 06/03/23 06/0317:26 06/03/2317:26
REPL
Replimune Group
Bristol-Myers
Replimune Group (REPL)… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Replimune presents RP1 data from IGNYTE trial at ASCO »
17:26 06/03/23 06/0317:26 06/03/2317:26
REPL
Replimune Group
Bristol-Myers
Replimune (REPL)… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
| Healthcare Analysts hold… Story temporarily locked. |
Hot Stocks
|
Janssen announces results from Phase 1b RedirecTT-1 study »
17:18 06/03/23 06/0317:18 06/03/2317:18
JNJ
Johnson & Johnson
The Janssen… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Evaxion's trial of EVX-01 met its primary endpoints of safety, tolerability »
17:09 06/03/23 06/0317:09 06/03/2317:09
EVAX
Evaxion Biotech
Evaxion Biotech presented… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Gracell presents long-term follow up data from study evaluating GC012F »
17:07 06/03/23 06/0317:07 06/03/2317:07
GRCL
Gracell
Gracell Biotechnologies… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Sutro Biopharma announces results from Phase 1 dose-expansion study of luvelta »
17:02 06/03/23 06/0317:02 06/03/2317:02
STRO
Sutro Biopharma
Sutro Biopharma announced… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Equitrans Midstream's Mountain Valley Pipeline to proceed »
16:58 06/03/23 06/0316:58 06/03/2316:58
ETRN
Equitrans Midstream
On June 3, 2023, the… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Cogent Biosciences announces data from ongoing Phase 3 PEAK trial »
16:56 06/03/23 06/0316:56 06/03/2316:56
COGT
Cogent Biosciences
Cogent Biosciences… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Gilead, Arcus announce updated results from interim analysis of ARC-7 study »
16:53 06/03/23 06/0316:53 06/03/2316:53
GILD
Gilead
Arcus Biosciences
Gilead Science (GILD) and… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
|
Alamo Group participates in a conference call with DA Davidson »
14:27 06/03/23 06/0314:27 06/03/2314:27
ALG
Alamo Group
Analyst Shlisky holds a… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
|
Alamo Group management to meet virtually with DA Davidson »
14:04 06/03/23 06/0314:04 06/03/2314:04
ALG
Alamo Group
Analyst Shlisky holds a… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
|
Peoples Bancorp management to meet virtually with DA Davidson »
13:59 06/03/23 06/0313:59 06/03/2313:59
PEBO
Peoples Bancorp
Analyst Navas holds a… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
NewAmsterdam's ROSE2 trial on obicetrapib met primary, secondary endpoints »
13:14 06/03/23 06/0313:14 06/03/2313:14
NAMS
NewAmsterdam
NewAmsterdam Pharma… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Precigen announces Phase 1 data of OTS PRGN-2009 AdenoVerse »
13:09 06/03/23 06/0313:09 06/03/2313:09
PGEN
Precigen
Precigen presented… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Elevation Oncology, CSPC announces initial clinical data for SYSA1801 »
13:02 06/03/23 06/0313:02 06/03/2313:02
ELEV
Elevation Oncology
CSPC
Elevation Oncology (ELEV)… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Blueprint Medicines announces data from its VELA trial of BLU-222 »
12:59 06/03/23 06/0312:59 06/03/2312:59
BPMC
Blueprint Medicines
Blueprint Medicines… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Blueprint Medicines announces results from its EGFR Programs »
12:59 06/03/23 06/0312:59 06/03/2312:59
BPMC
Blueprint Medicines
Blueprint Medicines… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Merck announces results from Phase 3 KEYNOTE-671 trial evaluating KEYTRUDA »
12:50 06/03/23 06/0312:50 06/03/2312:50
MRK
Merck
Merck, known as MSD… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Allogene Therapeutics presents updated ALLO-501/501A Phase 1 data »
12:45 06/03/23 06/0312:45 06/03/2312:45
ALLO
Allogene Therapeutics
Allogene Therapeutics… Story temporarily locked. ShowHide Related Items >><<
|